KNCV Tuberculosis Foundation is looking for full time
Study Coordinator for the IMPAACT4TB Project (1 position)
Duty station: Mzimba north, Mzuzu, Malawi
Information and application via https://www.kncvtbc.org/
KNCV Tuberculosis Foundation
KNCV Tuberculosis Foundation (KNCV) is one of the leading international non-profit organizations dedicated to fighting tuberculosis (TB) worldwide. We are an international center of expertise for TB control that stimulates effective, efficient, and sustainable tuberculosis control strategies in a national and international context. We are an organization of passionate TB professionals, including medical doctors, researchers, training experts, nurses, and epidemiologists.
Over the past century we have built a wealth of knowledge and expertise, initially by successfully driving back TB in the Netherlands, and subsequently by partnering in the fight against TB in over 40 countries worldwide.
We operate from a central office in The Hague in the Netherlands and additional country offices worldwide). KNCV raises funds from individual, institutional and corporate donors.
Latent tuberculosis (TB) infection (LTBI) is the seed bed for developing TB disease and continued transmission as it´s estimated that close to a quarter of the world’s population has LTBI. The World Health Organization (WHO) policy to give at least six months of isoniazid preventive therapy (IPT) to people living with HIV (PLWHIV) and child contacts has existed since 1993, yet the uptake of IPT in high burden countries remains poor. A short-course regimen of isoniazid and rifapentine weekly for three months (3HP) is now available. 3HP is associated with less toxicity, better adherence and at least similar efficacy to IPT and may be logistically easier for programs to scale up. WHO has included scaling up TB preventive therapy, particularly short-course regimens, in its End TB strategy Implementation of 3HP will meet the same fate as IPT unless existing barriers to its supply, adoption, demand and delivery are removed.
The IMPAACT4TB consortium is led by the Aurum Institute with core partners Clinton Health Access Initiative, Johns Hopkins University (JHU), KNCV Tuberculosis Foundation and the Global Drug Facility.
The goal of the IMPAACT4TB project is to reduce TB incidence among PLHIV and child contacts<5 living in low and middle-income countries by contributing to the sustainable scale up of 3HP preventive therapy. The project will utilize the UNITAID grant to start 400,000 people on 3HP and catalyze an increase in supply, demand for and uptake of 3HP in focus countries with the outcome of starting >1 million child contacts and PLWHIV on 3HP. JHU is leading a cluster randomized trial in Malawi called “Choice Architecture Based TB Preventive Therapy Prescribing” (CAT). The primary objective of this study is to use a feasible, low-resource strategy to achieve levels of 3HP delivery substantially higher than routine implementation in primary care public clinics. The study protocol received conditional approval from the WHO ERC in January, and from local IRB. KNCV is leading the implementation process in Ethiopia, Tanzania, Malawi, and Indonesia. Study Implementation has commenced in Malawi.
Purpose of the position and organizational position
KNCV is looking for a Study Coordinator who will be responsible for day-to-day activities in the intervention and control clinics participating in this trial in Mzimba North. He/she will be responsible for coordination of study activities at all study facilities in the district, supervision of research assistant, and documentation and reporting of ongoing study results, in close collaboration with study Co-Investigators at KNCV, DHOs, JHU, and the Ministry of Health. He/she is expected to uphold the study protocols and procedures in accordance with international standards. The Study Coordinator will report directly to the IMPAACT4TB Project Manager and will also maintain close communication and coordination with the M&E Officers and KNCV co-investigators.
Duties and responsibilities
As Study Coordinator you will:
Who are we looking for?
Knowledge and Experience
What does KNCV Tuberculosis Foundation offer?
Application and information
You can apply for this position by submitting your CV, including a motivation letter and 3 professional references, before May 25th, 2021 via https://www.kncvtbc.org/
Only shortlisted candidates will be contacted for interviews.
Please note that we only consider the applications that are received through the KNCV website. Applicants that are sent to recruit email account are not taken into consideration.